
Opinion|Videos|September 25, 2024 (Updated: September 25, 2024)
Advancing MDD Treatment: From STAR*D Insights to Precision Medicine and Novel Therapeutics
Key Takeaways
Experts in the management of mood disorders comment on the evolving management of major depressive disorder, emphasizing findings from the STAR*D trial, updated treatment guidelines, and the role of precision medicine and the shift toward personalized, rapid-acting treatments to improve patient outcomes.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
New 6-Month Data From Second Phase 3 Trial Confirms Rapid Effect of COMP360 for TRD
2
Take-Home Messages: Clinical Confidence in Transitioning Patients to Cobenfy
3
Phase 2 Trial Initiated for Briumvi for Treatment-Resistant Schizophrenia
4
Developments in Cannabis Withdrawal and Addiction Treatment
5








